Getting Ready: Drug Traceability
June 5, 2021

Getting Ready: Drug Traceability

Published June 5th, 2021 As the community prepares for the GS1 Connect 2021: Digital Edition conference next week, the FDA issued new guidance to further enhance the security of prescription drugs in the supply chain. This guidance is intended to assist trading partners in complying with the law and achieving a safer, more secure, and […]
Read More
Enhanced Drug Distribution Security at the Package Level under DSCSA
June 4, 2021

Enhanced Drug Distribution Security at the Package Level under DSCSA

Published June 4th, 2021 On June 3rd, 2021, the FDA provided new guidance to further enhance the security of prescription drugs in the U.S. supply chain. To help stakeholders understand the emerging DSCSA requirements FDA published four guidance documents to assist trading partners in complying with the law and achieving a safer, more secure, and […]
Read More
FDA In Brief: FDA provides new guidance to further enhance the security of prescription drugs in the U.S. supply chain
June 3, 2021

FDA In Brief: FDA provides new guidance to further enhance the security of prescription drugs in the U.S. supply chain

June 03, 2021 The following quote is attributed to Donald D. Ashley, J.D., Director of the Office of Compliance for FDA’s Center for Drug Evaluation and Research “Ensuring the quality of prescription drugs and safeguarding the integrity of pharmaceutical distribution are crucial roles the FDA plays in protecting the health of the American public. Illegitimate […]
Read More
We Will Be Presenting at This Year’s GS1 Connect Conference
May 26, 2021

We Will Be Presenting at This Year’s GS1 Connect Conference

We will be presenting at this year’s GS1 Connect Conference: An Automated Approach to Drug Traceability Readiness with speaker Gary Lerner, President Gateway Checker Corporation – This presentation will examine enhanced drug distribution security requirements and what it means for industry participants from an information exchange perspective. In short, the enhanced drug distribution security aspect of DSCSA mandates the exchange of a transaction record it each change of ownership.
Read More
VRS System Verification at HDA 2020 Traceability Seminar
October 30, 2020

VRS System Verification at HDA 2020 Traceability Seminar

As you know, the FDA recently extended saleable returns verification until 2023. Please join Gateway Checker CEO and Founder Gary Lerner at the HDA 2020 Virtual Traceability Seminar where he is hosting a VRS System Verification roundtable on Tuesday, November 3 at 10:00 AM ET. We will address the FDA’s saleable returns verification extension and […]
Read More